California AB1990 regulates the advertising and distribution of compounded medications for obesity or weight management.
California AB1990 establishes safety and regulatory requirements for compounded medications used for obesity or weight management. It mandates that entities selling or distributing these medications must maintain records and provide them upon request. The bill requires compounded medications to use pharmaceutical-grade active ingredients and comply with quality control testing. It prohibits advertising these medications unless it includes detailed risk information and a clear statement that the medication is not FDA-approved. Violations result in fines and potential license revocation.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.